Redeye adjusts our growth assumptions slightly for 2023e and beyond. The Q1 confirms our conviction in the long-term case. With the minor estimate changes, our Base case remains at SEK 36 per share. The current share prices offer a good entry point to a long-term growth story.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Tobii Dynavox - Steady progress in Q1

© Modular Finance, source Nordic Press Releases